Short Ideas - Quarterly results for Amedisys Inc. (NASDAQ:AMED) were exceptionally poor as we reported on Tuesday (here), and the follow through from analysts Wednesday morning is highly … Continue Reading
Read nowLong Ideas - Spectrum Pharmaceuticals (NASDAQ:SPPI) reported adjusted 3Q 2012 earnings per share (EPS) of $0.42, beating the Consensus estimate of $0.27. Revenues for the period came in … Continue Reading
Read nowQuick Picks - Amedisys, Inc. (NASDAQ:AMED) reported 3Q 2012 earnings per share (EPS) of $0.33. The results appear to be better-than-expected given the $0.27 Consensus estimate, however, excluding … Continue Reading
Read nowLong Ideas - Endo Pharmaceuticals (NASDAQ:ENDP) reported 3Q 2012 adjusted EPS of $1.28, ahead of the Consensus estimate of $1.26. However, revenues for the period came in at … Continue Reading
Read nowMost Popular - Shares of Questcor Pharmaceuticals (NASDAQ:QCOR) are under pressure Friday, down 10% in morning trading on news that unknown drug company Cerium Pharmaceuticals has received Orphan … Continue Reading
Read nowLong Ideas - Shares of Endo Pharmaceuticals (NASDAQ:ENDP) are trading at a deep discount to other pharmaceutical companies, with the last dip in price coming on the heels … Continue Reading
Read nowShort Ideas - Shares of Pain Therapeutics (NASDAQ:PTIE) are off 25% as partner Pfizer (NYSE:PFE) noted Thursday on its earnings call that Remoxy, PTIE’s lead product, is a … Continue Reading
Read now